ATE121296T1 - Igf-i zur behandlung von nebeneffekten der steroidtherapie. - Google Patents

Igf-i zur behandlung von nebeneffekten der steroidtherapie.

Info

Publication number: ATE121296T1
Authority: AT; Austria
Prior art keywords: igf; treatment; side effects; steroid therapy; steroid
Prior art date: 1989-12-22

Application number

AT90810987T

Other languages

English (en)

Inventor

Ronald L Goldberg

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-12-22

Filing date

1990-12-13

Publication date

1995-05-15

1990-12-13 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1995-05-15 Application granted granted Critical

1995-05-15 Publication of ATE121296T1 publication Critical patent/ATE121296T1/de

Links

102000004218 Insulin-Like Growth Factor I Human genes 0.000 title abstract 3
108090000723 Insulin-Like Growth Factor I Proteins 0.000 title abstract 3
230000000694 effects Effects 0.000 title abstract 2
150000003431 steroids Chemical class 0.000 title abstract 2
238000002560 therapeutic procedure Methods 0.000 title 1
230000002411 adverse Effects 0.000 abstract 1
210000000845 cartilage Anatomy 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000037314 wound repair Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Immunology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Medicines Containing Plant Substances (AREA)

AT90810987T 1989-12-22 1990-12-13 Igf-i zur behandlung von nebeneffekten der steroidtherapie. ATE121296T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US45521589A	1989-12-22	1989-12-22

Publications (1)

Publication Number	Publication Date
ATE121296T1 true ATE121296T1 (de)	1995-05-15

Family

ID=23807878

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90810987T ATE121296T1 (de)	1989-12-22	1990-12-13	Igf-i zur behandlung von nebeneffekten der steroidtherapie.

Country Status (14)

Country	Link
EP (1)	EP0434625B1 (de)
JP (1)	JP2934023B2 (de)
KR (1)	KR100191381B1 (de)
AT (1)	ATE121296T1 (de)
AU (1)	AU641966B2 (de)
CA (1)	CA2032859C (de)
DE (1)	DE69018799T2 (de)
DK (1)	DK0434625T3 (de)
ES (1)	ES2071080T3 (de)
GR (1)	GR3015900T3 (de)
IE (1)	IE67510B1 (de)
IL (1)	IL96711A (de)
NZ (1)	NZ236614A (de)
ZA (1)	ZA9010332B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5128320A (en) *	1990-01-18	1992-07-07	Genentech, Inc.	Method of restoring normal growth, weight gain or lean body mass in patients with glucocorticoid excess by administering igf-i
TW267102B (de)	1992-03-13	1996-01-01	Ciba Geigy
US5407913A (en) *	1992-12-03	1995-04-18	Celtrix Pharmaceuticals, Inc.	Method and composition for systemic treatment of tissue injury
EP0779927A1 (de) *	1994-09-08	1997-06-25	Chiron Corporation	Methode zur gesteigerten herstellung von insulin-ähnlichem wachstumsfaktor
US5728676A (en) *	1994-09-08	1998-03-17	Ciba-Geigy Corporation	Use of insulin-like growth factors I and II for inhibition of inflammatory response
AU7271996A (en) *	1995-10-23	1997-05-15	Queen's University At Kingston	Method and pharmaceutical composition for chondrostimulation with a prostaglandin (e.g. misoprostol) and tgf-beta, optionally in combination with igf-1
WO1998011913A1 (en) *	1996-09-16	1998-03-26	Dalhousie University	Use of igf-i for the treatment of polycystic kidney disease and related indications
US6015786A (en) *	1997-02-25	2000-01-18	Celtrix Pharmaceuticals, Inc.	Method for increasing sex steroid levels using IGF or IGF/IGFBP-3
US6514937B1 (en)	1997-02-25	2003-02-04	Celtrix Pharmaceuticals, Inc.	Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
US6025368A (en) *	1997-02-25	2000-02-15	Celtrix Pharmaceuticals, Inc.	Method for treating the symptoms of chronic stress-related disorders using IGF
AU3548999A (en)	1998-04-03	1999-10-25	Chiron Corporation	Use of igfi for treating articular cartilage disorders
AU762351B2 (en)	1999-01-06	2003-06-26	Genentech Inc.	Insulin-like growth factor (IGF) I mutant variants
ATE389416T1 (de)	2000-05-16	2008-04-15	Genentech Inc	Behandlung von knorpelerkrankungen
EP1917039A4 (de) *	2005-08-01	2011-01-19	Genera Istrazivanja D O O	Verfahren und zusammensetzungen zur regeneration von gelenkknorpel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE88899T1 (de) *	1986-11-14	1993-05-15	Inst Molecular Biology Inc	Wundheilung und knochenregeneration.
SE8703625D0 (sv) *	1987-09-18	1987-09-18	Kabivitrum Ab	New medical use
US4983581A (en) *	1988-05-20	1991-01-08	Institute Of Molecular Biology, Inc.	Wound healing composition of IGF-I and TGF-β

1990
- 1990-12-12 ZA ZA9010332A patent/ZA9010332B/xx unknown
- 1990-12-13 AT AT90810987T patent/ATE121296T1/de not_active IP Right Cessation
- 1990-12-13 ES ES90810987T patent/ES2071080T3/es not_active Expired - Lifetime
- 1990-12-13 DK DK90810987.9T patent/DK0434625T3/da active
- 1990-12-13 EP EP90810987A patent/EP0434625B1/de not_active Expired - Lifetime
- 1990-12-13 DE DE69018799T patent/DE69018799T2/de not_active Expired - Fee Related
- 1990-12-18 IL IL9671190A patent/IL96711A/en not_active IP Right Cessation
- 1990-12-19 AU AU68247/90A patent/AU641966B2/en not_active Ceased
- 1990-12-20 CA CA002032859A patent/CA2032859C/en not_active Expired - Fee Related
- 1990-12-20 KR KR1019900021111A patent/KR100191381B1/ko not_active Expired - Fee Related
- 1990-12-21 JP JP2405132A patent/JP2934023B2/ja not_active Expired - Fee Related
- 1990-12-21 IE IE468490A patent/IE67510B1/en not_active IP Right Cessation
- 1990-12-21 NZ NZ236614A patent/NZ236614A/xx unknown
1995
- 1995-04-20 GR GR950400745T patent/GR3015900T3/el unknown

Also Published As

Publication number	Publication date
NZ236614A (en)	1993-10-26
IL96711A0 (en)	1991-09-16
CA2032859A1 (en)	1991-06-23
JPH04210648A (ja)	1992-07-31
IE904684A1 (en)	1991-07-17
ZA9010332B (en)	1991-08-28
EP0434625A3 (en)	1991-10-02
DE69018799D1 (de)	1995-05-24
GR3015900T3 (en)	1995-07-31
EP0434625B1 (de)	1995-04-19
JP2934023B2 (ja)	1999-08-16
DE69018799T2 (de)	1995-09-21
KR100191381B1 (ko)	1999-06-15
KR910011279A (ko)	1991-08-07
CA2032859C (en)	2007-09-17
AU641966B2 (en)	1993-10-07
IL96711A (en)	1996-01-19
IE67510B1 (en)	1996-04-03
AU6824790A (en)	1991-06-27
DK0434625T3 (da)	1995-06-26
EP0434625A2 (de)	1991-06-26
ES2071080T3 (es)	1995-06-16

Legal Events

Date	Code	Title	Description
1995-10-15	UEP	Publication of translation of european patent specification
2009-09-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69018799D1 (de)	1995-05-24	IGF-I zur Behandlung von Nebeneffekten der Steroidtherapie.
DE69016768D1 (de)	1995-03-23	Zusammensetzung und Verfahren für die Behandlung von Osteoporose bei Säugetieren.
ATE187889T1 (de)	2000-01-15	Vorbeugung und behandlung der peripheren neuropathie
ATE186840T1 (de)	1999-12-15	Zusammensetzungen und methoden zur wundbehandlung
ES2113857T3 (es)	1998-05-16	Composiciones osteoinductoras.
ATE223486T1 (de)	2002-09-15	Bmp-9 zusammensetzungen
DE3779149D1 (de)	1992-06-25	Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
DE122009000012I1 (de)	2011-12-01	Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE60013266D1 (de)	2004-09-30	Steroidnitrate zur behandlung von oxidativen schädigungen und endothelialer dysfunktion
DE3579129D1 (de)	1990-09-13	Zusammensetzung und verfahren zur behandlung von kunststoffen mit alkalipermanganat-loesungen.
ATE178206T1 (de)	1999-04-15	Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie
DE69431199D1 (de)	2002-09-26	Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
EP0711159A4 (de)	1998-01-14	Verfahren und zusammensetzungen zur behandlung von asthma, arthereosklerose und entzuendlichen erkrankungen unter verwendung von optisch reinem (-)-zilenton
DE59103291D1 (de)	1994-11-24	Verfahren zur bekämpfung von samen- und/oder bodenbürtigen schaderregern durch saatgutbehandlung.
ATE110961T1 (de)	1994-09-15	Behandlung von beatmungsabhängigkeit mit wachstumshormon.
ATE178336T1 (de)	1999-04-15	Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
DE69022027D1 (de)	1995-10-05	2-Alkyl-3-benzoylbenzofurane zur Behandlung von Herzarrhythmia.